Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2258 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Watson files two ANDAs for generic Mucinex

Watson said that its guaifenesin and dextromethorphan HBr/guaifenesin extended-release tablet products are the generic versions of Reckitt Benckiser’s Mucinex and Mucinex DM products which are indicated to help

Targacept initiates Phase II hypertension trial

The design for the double-blind, placebo-controlled Phase II exploratory study of TC-5214 provides for approximately 12 subjects with resistant hypertension to receive either a single escalating dose of

Opko Health names new board member

Dr Yu is a distinguished research fellow and associate director at the Genomics Research Center, Academia Sinica, in Taiwan. She also serves as a professor of pediatrics for

Fluke acquires Hawk IR International

Hawk IR will continue to operate as Hawk IR International under the Fluke electronics industrial division and will continue to service its customers and partners globally. Fluke said

InteRNA Technologies and Radboud UNMC sign research agreement

Under the research collaboration with professor Jack Schalken (laboratory of experimental urology), InteRNA’s lentiviral-based microRNA (miRNA) overexpression library will be applied in multi-parametric, high-throughput functional screening assays to

Metabolex names new board member

Currently Sherman is a senior vice president and general manager. He will report to John E. McGlade, chairman, president and chief executive officer. He will have responsibility for